Nancy Villa

1.3k total citations
33 papers, 944 citations indexed

About

Nancy Villa is a scholar working on Molecular Biology, Genetics and Epidemiology. According to data from OpenAlex, Nancy Villa has authored 33 papers receiving a total of 944 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 13 papers in Genetics and 7 papers in Epidemiology. Recurrent topics in Nancy Villa's work include Virus-based gene therapy research (13 papers), RNA and protein synthesis mechanisms (7 papers) and CAR-T cell therapy research (4 papers). Nancy Villa is often cited by papers focused on Virus-based gene therapy research (13 papers), RNA and protein synthesis mechanisms (7 papers) and CAR-T cell therapy research (4 papers). Nancy Villa collaborates with scholars based in United States, Netherlands and Italy. Nancy Villa's co-authors include Christopher S. Fraser, Grant McFadden, Thomas J. Lyons, Brian R. Kupchak, John W.B. Hershey, Leiliang Zhang, Ibon Garitaonandia, Jessica L. Smith, Masmudur M. Rahman and David Eide and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Nancy Villa

33 papers receiving 935 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nancy Villa United States 19 593 236 169 127 95 33 944
Renato Bruni United States 13 564 1.0× 160 0.7× 281 1.7× 134 1.1× 39 0.4× 20 1.0k
Natacha Klages Switzerland 19 790 1.3× 285 1.2× 260 1.5× 90 0.7× 145 1.5× 22 1.6k
Katarzyna Kulej United States 18 688 1.2× 144 0.6× 180 1.1× 137 1.1× 38 0.4× 30 1.0k
Jessica M. Jones United States 21 756 1.3× 246 1.0× 124 0.7× 78 0.6× 33 0.3× 26 1.2k
Edio Maldonado Chile 19 1.7k 2.8× 255 1.1× 156 0.9× 159 1.3× 147 1.5× 36 2.1k
Elizabeth Mathew United States 13 323 0.5× 187 0.8× 199 1.2× 69 0.5× 186 2.0× 28 740
Iraad F. Bronner United Kingdom 12 485 0.8× 71 0.3× 168 1.0× 68 0.5× 60 0.6× 16 1.2k
Pablo C. Echeverría Argentina 22 1.0k 1.8× 206 0.9× 213 1.3× 205 1.6× 47 0.5× 32 1.6k
Heike Kollmus Germany 18 548 0.9× 83 0.4× 159 0.9× 71 0.6× 36 0.4× 31 1.0k
Xavier Cayla France 26 1.1k 1.9× 116 0.5× 124 0.7× 168 1.3× 69 0.7× 48 1.5k

Countries citing papers authored by Nancy Villa

Since Specialization
Citations

This map shows the geographic impact of Nancy Villa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nancy Villa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nancy Villa more than expected).

Fields of papers citing papers by Nancy Villa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nancy Villa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nancy Villa. The network helps show where Nancy Villa may publish in the future.

Co-authorship network of co-authors of Nancy Villa

This figure shows the co-authorship network connecting the top 25 collaborators of Nancy Villa. A scholar is included among the top collaborators of Nancy Villa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nancy Villa. Nancy Villa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Villa, Nancy & Christopher S. Fraser. (2024). Human eukaryotic initiation factor 4G directly binds the 40S ribosomal subunit to promote efficient translation. Journal of Biological Chemistry. 300(5). 107242–107242. 4 indexed citations
2.
Franzo, Giovanni, et al.. (2022). First detection of porcine circovirus type 2e in Europe. The Veterinary Journal. 279. 105787–105787. 4 indexed citations
3.
Lapointe, Christopher P., Rosslyn Grosely, Masaaki Sokabe, et al.. (2022). eIF5B and eIF1A reorient initiator tRNA to allow ribosomal subunit joining. Nature. 607(7917). 185–190. 38 indexed citations
4.
Sokabe, Masaaki, et al.. (2022). Human eukaryotic initiation factor 4E (eIF4E) and the nucleotide-bound state of eIF4A regulate eIF4F binding to RNA. Journal of Biological Chemistry. 298(10). 102368–102368. 5 indexed citations
5.
Villa, Nancy, Masmudur M. Rahman, Meaghen E. Sharik, et al.. (2022). Transplantation of autologous bone marrow pre-loaded ex vivo with oncolytic myxoma virus is efficacious against drug-resistant Vk*MYC mouse myeloma. Oncotarget. 13(1). 490–504. 4 indexed citations
6.
Villa, Nancy, Masmudur M. Rahman, Jacquelyn Kilbourne, et al.. (2020). Autologous Transplantation Using Donor Leukocytes Loaded Ex Vivo with Oncolytic Myxoma Virus Can Eliminate Residual Multiple Myeloma. Molecular Therapy — Oncolytics. 18. 171–188. 11 indexed citations
7.
Glenn, Honor L., Ana Lemos de Matos, Nancy Villa, & Grant McFadden. (2020). Microscopic Analysis of Viral Infection. Methods in molecular biology. 2225. 163–177. 1 indexed citations
8.
Jazowiecka-Rakus, Joanna, Aleksander Sochanik, Aleksandra Rusin, et al.. (2020). Myxoma Virus-Loaded Mesenchymal Stem Cells in Experimental Oncolytic Therapy of Murine Pulmonary Melanoma. Molecular Therapy — Oncolytics. 18. 335–350. 28 indexed citations
9.
Villa, Nancy, et al.. (2019). The CXCR4-LASP1-eIF4F Axis Promotes Translation of Oncogenic Proteins in Triple-Negative Breast Cancer Cells. Frontiers in Oncology. 9. 284–284. 19 indexed citations
10.
Villa, Nancy & Grant McFadden. (2018). Virotherapy as Potential Adjunct Therapy for Graft-Vs-Host Disease. Current Pathobiology Reports. 6(4). 247–263. 7 indexed citations
11.
Villa, Nancy, Ana Lemos de Matos, Tom Hofland, et al.. (2016). Ex Vivo Oncolytic Virotherapy with Myxoma Virus Arms Multiple Allogeneic Bone Marrow Transplant Leukocytes to Enhance Graft versus Tumor. Molecular Therapy — Oncolytics. 4. 31–40. 26 indexed citations
12.
Villa, Nancy, Winnie Chan, Amy Meacham, et al.. (2016). Ex vivo virotherapy with myxoma virus does not impair hematopoietic stem and progenitor cells. Cytotherapy. 18(3). 465–480. 21 indexed citations
13.
Villa, Nancy, Clive Wasserfall, Amy Meacham, et al.. (2015). Myxoma virus suppresses proliferation of activated T lymphocytes yet permits oncolytic virus transfer to cancer cells. Blood. 125(24). 3778–3788. 33 indexed citations
14.
Villa, Nancy, et al.. (2013). Human Eukaryotic Initiation Factor 4G (eIF4G) Protein Binds to eIF3c, -d, and -e to Promote mRNA Recruitment to the Ribosome. Journal of Biological Chemistry. 288(46). 32932–32940. 120 indexed citations
16.
Canal, Clinton E., et al.. (2011). Drug discovery targeting human 5-HT2C receptors: Residues S3.36 and Y7.43 impact ligand—Binding pocket structure via hydrogen bond formation. European Journal of Pharmacology. 673(1-3). 1–12. 20 indexed citations
17.
Villa, Nancy, Patricia Moussatche, Stephen G. Chamberlin, Anuj Kumar, & Thomas J. Lyons. (2011). Phylogenetic and Preliminary Phenotypic Analysis of Yeast PAQR Receptors: Potential Antifungal Targets. Journal of Molecular Evolution. 73(3-4). 134–152. 21 indexed citations
18.
Villa, Nancy, Eric Bartee, Mohamed R. Mohamed, et al.. (2010). Myxoma and vaccinia viruses exploit different mechanisms to enter and infect human cancer cells. Virology. 401(2). 266–279. 23 indexed citations
19.
Villa, Nancy, Brian R. Kupchak, Ibon Garitaonandia, et al.. (2008). Sphingolipids Function as Downstream Effectors of a Fungal PAQR. Molecular Pharmacology. 75(4). 866–875. 68 indexed citations
20.
Kupchak, Brian R., et al.. (2007). Probing the mechanism of FET3 repression by Izh2p overexpression. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1773(7). 1124–1132. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026